Riskpilot← Back to searchSign inGet full accessMedifactia AB
ABActiveOrg 5569194409Kungsgatan 60Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20131 employees
Revenue 2024
SEK 1,7M
-7% vs 2023
EBITDA margin
-19.0%
+47% vs 2023
Equity ratio
74.1%
Financial strength
Net profit 2024
SEK -542K
+46% vs 2023
| Revenue | SEK 1,7M | -7% |
| EBITDA | SEK -328K | +47% |
| Net profit | SEK -542K | +46% |
| Total assets | SEK 1,5M | +28% |
| Equity | SEK 1,1M | +130% |
| Employees | 1 | — |
Legal name
Medifactia AB
Org number
5569194409
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18 januari 2013
Share capital
SEK 180 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva produktion, försäljning, import och export av medicinskt diagnostiskt material samt konsultverksamhet i medicinsk diagnostik.
Address
Kungsgatan 60
Email
diana.nystrom@medifactia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 779 | 1 545 | 1 439 | 3 016 | 2 476 | 1 842 | 1 722 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −335 | −914 | −575 | −206 | 358 | 431 | 1 121 | 40 | −617 | −328 |
| Depreciation & amort. | −0 | −0 | −3 | −46 | −236 | −273 | −273 | −345 | −377 | −214 |
| EBIT | −335 | −914 | −578 | −252 | 122 | 158 | 848 | −305 | −994 | −542 |
| Net financials | −29 | −39 | −24 | −12 | −1 | −60 | −15 | −7 | — | −1 |
| Profit before tax | −364 | −953 | −602 | −265 | 121 | 98 | 833 | −312 | −993 | −542 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −5 | −0 |
| Net profit | −364 | −953 | −602 | −265 | 121 | 98 | 833 | −312 | −998 | −542 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 377 | 854 | 443 | 1 071 | 1 449 | 1 327 | 2 453 | 2 085 | 1 131 | 1 450 |
| Equity | −74 | 339 | −46 | 564 | 685 | 805 | 1 638 | 1 326 | 468 | 1 075 |
| Long-term debt | 434 | 209 | 183 | 125 | 125 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 | 306 | 306 | 382 | 640 | 522 | 815 | 759 | 663 | 375 |
| Total debt | 451 | 515 | 489 | 507 | 765 | 522 | 815 | 759 | 663 | 375 |
EBITDA margin
-19.0%
This company
15.8%
Market median
-220% vs market
20152024
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
20152024
Return on equity
-50.4%
This company
18.4%
Market median
-374% vs market
20152024
Net profit margin
-31.5%
This company
8.1%
Market median
-489% vs market
20152024
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
20152024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DT Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scandinavian Tech Holding 3 AB | Company | 78.0% | 78.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scandinavian Tech Holding 3 AB
Medifactia AB Board members of Medifactia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Torbjörn Johansson | Chief Auditor | 0 companies |
| Edward Azaria Antov | Deputy Board Member | 0 companies |
| Frantz-Lys Cajuste | Board of Directors | 0 companies |
| Siv Diana Nyström | Chairman | 0 companies |